Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label oral ketamine for psychogenic non-epileptic seizures
ACTRN12621001127897Phase 2Not yet recruiting
- Sponsor
- University of Otago
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ketamine in Dissociative convulsions (PNES), sponsored by University of Otago. Primary endpoint: Change in average non-epileptic seizure frequency. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
ketamine
03
Conditions
Dissociative convulsions (PNES)
Beyond the preview
Go deeper on ACTRN12621001127897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001127897.